Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Conditions
Ovarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

carboplatin

DRUG

oglufanide disodium

DRUG

paclitaxel

PROCEDURE

conventional surgery

Trial Locations (19)

20007

Lombardi Cancer Center, Washington D.C.

30322

Winship Cancer Institute, Atlanta

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

55455

University of Minnesota Cancer Center, Minneapolis

63110

Washington University School of Medicine, St Louis

67214

University of Kansas School of Medicine-Wichita, Wichita

89030

Women's Cancer Center - Las Vegas, Las Vegas

91204

Comprehensive Cancer Center, Glendale

95032

Community Hospital of Los Gatos, Los Gatos

98195

University of Washington School of Medicine, Seattle

94305-5408

Stanford University Medical Center, Stanford

68198-3330

University of Nebraska Medical Center, Omaha

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

43210-1240

Arthur G. James Cancer Hospital - Ohio State University, Columbus

15213-3180

Magee-Womens Hospital, Pittsburgh

05401

Fletcher Allen Health Care - Medical Center Campus, Burlington

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cytran

INDUSTRY